Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
The British Journal of Dermatology
|
April 17, 2010
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
R G Langley, B E Strober, Y Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1999
Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus
T J Vyse, R K Halterman, S J Rozzo, et al.
The Journal of Allergy and Clinical Immunology
|
February 1, 1988
Human tonsillar IgE biosynthesis in vitro. II. Analysis of T cell regulation with monoclonal antibodies
K Ohta, S J Rozzo, A R Hayward, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
T J Vyse, S J Rozzo, C G Drake, et al.
Immunological Reviews
|
April 1, 1995
Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice
C G Drake, S J Rozzo, T J Vyse, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 13, 2019
Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials
R Bissonnette, P Fernández-Peñas, L Puig, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1994
Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus
S J Rozzo, C G Drake, B L Chiang, et al.
The Journal of Clinical Investigation
|
October 15, 1996
Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice
T J Vyse, C G Drake, S J Rozzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice
S J Rozzo, T J Vyse, C S David, et al.
The British Journal of Dermatology
|
August 14, 2012
An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals
U Mrowietz, K Kragballe, K Reich, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
The British Journal of Dermatology
|
April 17, 2010
Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
R G Langley, B E Strober, Y Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1999
Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus
T J Vyse, R K Halterman, S J Rozzo, et al.
The Journal of Allergy and Clinical Immunology
|
February 1, 1988
Human tonsillar IgE biosynthesis in vitro. II. Analysis of T cell regulation with monoclonal antibodies
K Ohta, S J Rozzo, A R Hayward, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1997
Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
T J Vyse, S J Rozzo, C G Drake, et al.
Immunological Reviews
|
April 1, 1995
Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice
C G Drake, S J Rozzo, T J Vyse, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 13, 2019
Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials
R Bissonnette, P Fernández-Peñas, L Puig, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1994
Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus
S J Rozzo, C G Drake, B L Chiang, et al.
The Journal of Clinical Investigation
|
October 15, 1996
Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice
T J Vyse, C G Drake, S J Rozzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice
S J Rozzo, T J Vyse, C S David, et al.
The British Journal of Dermatology
|
August 14, 2012
An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals
U Mrowietz, K Kragballe, K Reich, et al.
Page
of 4